BHS 003
Alternative Names: BHS-003Latest Information Update: 29 Sep 2020
At a glance
- Originator BioHybrid Solutions
- Class Drug conjugates; Protein-drug conjugates; Proteins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Immunological disorders
Most Recent Events
- 29 Sep 2020 Early research in Immunological disorders in USA (unspecified route) (BioHybrid Solutions, September 2020)
- 01 Mar 2016 BioHybrid Solutions in-licenses NanoArmored™ technology from Carnegie Mellon University (BioHybrid Solutions website, September 2020)